MedTrace Logo

A Bifido Bacteria to Improve Lactose Digestion and Tolerance

NCT05668468 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-12-29

No results posted yet for this study

Summary

We want to determine if feeding a bifido bacteria that readily digests lactose and galactooligosacharides improves lactose digestion and tolerance through alteration of the microbiome.

Conditions

  • Lactose Intolerance

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium adolescentis IVS-1 capsule

Daily Bifidobacterium adolescentis IVS-1 capsule containing up to 6x10 ninth cfu per capsule or daily cellulose capsule

OTHER

Placebo cellulose capsule

Daily cellulose capsule

Sponsors & Collaborators

  • Purdue University

    lead OTHER

Principal Investigators

  • Dennis Savaiano, PhD · Purdue University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05668468 on ClinicalTrials.gov